Clinical Features

Novel Agents in HER2-Positive Breast Cancer

Two new and exciting clinical trials for HER2-positive breast cancer are now open and recruiting in Ireland - Novel Agents in HER2-Positive

By Danielle Norton March 1, 2022 Updated July 4, 2022 8 min read

Written by Maeve A. Hennessy, Kate Rafferty, Catherine M. Kelly Dept. of Medical Oncology, Mater Misericordiae University Hospital

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation Cancel reply

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free